Implementing emicizumab in hemophilia inhibitor management: emicizumab should be prescribed after tolerance.
PubMed 文献 · Blood Adv · 2018-01-01
This article has a companion Counterpoint by Le Quellec and Negrier.
原文
This article has a companion Counterpoint by Le Quellec and Negrier.
来源:Blood Adv,查看原文。版权归原作者所有。
引用
- Young G. Implementing emicizumab in hemophilia inhibitor management: emicizumab should be prescribed after tolerance. Blood Adv. 2018. PMID: 30352951. doi:10.1182/bloodadvances.2018015842
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。